Market

Share Holding Pattern

You can view the Ratio Analysis for the last 5 years.

RATIOS

Aristo Bio-Tech and Lifescience Ltd.

GO
Market Cap. ( ₹ in Cr. ) 89.86 P/BV 2.67 Book Value ( ₹ ) 49.37
52 Week High/Low ( ₹ ) 164/63 FV/ML 10/1600 P/E(X) 23.07
Book Closure 15/09/2023 EPS ( ₹ ) 5.72 Div Yield (%) 0.00

ParticularsMar 24Mar 23Mar 22Mar 21Mar 20
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)5.726.722.932.150.19
Diluted EPS (Rs.)5.726.722.932.150.19
Cash EPS (Rs.)8.037.495.133.652.98
Book Value[Excl.RevalReserv]/Share (Rs.)49.3744.3029.7126.7924.77
Book Value[Incl.RevalReserv]/Share (Rs.)49.3744.3029.7126.7924.77
Dividend / Share (Rs.)0.400.250.000.000.00
Revenue From Operations / Share (Rs.)360.10320.01332.31334.77400.66
PBDIT / Share (Rs.)12.7413.2611.028.729.04
PBIT / Share (Rs.)10.4311.018.827.228.00
PBT / Share (Rs.)7.946.964.093.002.79
Net Profit / Share (Rs.)5.725.232.932.151.94
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)3.534.143.312.602.25
PBIT Margin (%)2.893.432.652.151.99
PBT Margin (%)2.202.171.220.890.69
Net Profit Margin (%)1.581.630.880.640.48
Return on Networth / Equity (%)11.5911.819.848.037.81
Return on Capital Employeed (%)16.2418.5716.9114.1717.32
Return On Assets (%)3.063.561.891.321.10
Long Term Debt / Equity (X)0.290.330.740.900.86
Total Debt / Equity (X)0.620.741.721.661.48
Asset Turnover Ratio (%)2.162.462.101.972.24
      
LIQUIDITY RATIOS     
      
Current Ratio (X)1.261.401.231.231.18
Quick Ratio (X)0.770.870.740.660.80
Inventory Turnover Ratio (X)6.297.194.924.405.38
Dividend Payout Ratio (NP) (%)11.350.000.000.000.00
Dividend Payout Ratio (CP) (%)8.090.000.000.000.00
Earning Retention Ratio (%)88.650.000.000.000.00
Cash Earning Retention Ratio (%)91.910.000.000.000.00
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)5.123.282.332.071.74
Interest Coverage Ratio (Post Tax) (%)3.302.291.621.511.37
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)62.7558.800.000.000.00
EV / Net Operating Revenue (X)0.250.260.000.000.00
EV / EBITDA (X)7.246.510.000.000.00
MarketCap / Net Operating Revenue (X)0.170.170.000.000.00
Retention Ratios (%)88.640.000.000.000.00
Price / BV (X)1.261.270.000.000.00
Price / Net Operating Revenue (X)0.170.170.000.000.00
EarningsYield0.090.090.000.000.00